Abstract
COULD FAVIPIRAVIR BE AN EFFECTIVE AND SAFE OPTION FOR THE MANAGEMENT OF COVID-19?

Mohammed G. Maslub*, Mahasen A. Radwan, Mina S. Mikhail and Zeyad A. Abdalla

ABSTRACT

Through the ongoing world war against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) plague, a definite rational anti-viral treatment for corona virus disease 2019 (COVID-19) is still absent. Favipiravir (FPV), as an antiviral agent, demonstrates effectiveness towards Oseltamivir (OTV)-resistant influenza, and numerous RNA viruses. The aim of this work was to review both the FPV safety and effectiveness in managing SARS-CoV-2. A thorough search for relevant articles in the databases on the Egyptian Knowledge Bank limited to the period 12/4/2015 - 12/7/2020 was performed. Preference was given to articles concerning the therapeutic options for treating COVID-19 including FPV principally. Twenty six articles were selected. Six cited articles have reported FPV effectiveness towards several RNA viruses, while, 5 articles reported FPV potential activity towards SARS-CoV-2. Sixty-five% of the articles stated current investigations testing the effectiveness of FPV with other combinations in treating SARS-CoV-2. Only 1 article studied the adverse reaction of FPV. Although it is too early to give a final recommendation of using any medication for the exponentially spreading COVID-19, 20 of the articles revealed FPV activity against various RNA viruses particularly, resistant types. Japan has approved FPV for the treatment of pandemic influenza and China encouraged the use of it for SARS-CoV-2 treatment. Therefore, FPV could be a promising antiviral treatment as it is relatively safe in comparison to other treatment options for COVID-19.

Keywords: COVID-19, coronavirus, SARS-CoV-2, pandemic, favipiravir, coronavirus treatment.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • EJBPS: MARCH ISSUE PUBLISHED

    MARCH 2021 Issue has been successfully launched on 1 March 2021.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT